447 related articles for article (PubMed ID: 34551665)
1. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
3. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
Alkholief M; Kalam MA; Anwer MK; Alshamsan A
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
[TBL] [Abstract][Full Text] [Related]
4. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
5. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer tumour antigen, MUC-1 peptide-loaded non-aggregated poly (lactide-
Jyoti K; Jain S; Katare OP; Katyal A; Chandra R; Madan J
J Microencapsul; 2020 Jan; 37(1):14-28. PubMed ID: 31718364
[No Abstract] [Full Text] [Related]
7. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
[TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
10. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
Hussein AS; Abdullah N; Ahmadun FR
IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
[TBL] [Abstract][Full Text] [Related]
11. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
14. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
15. Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro-in vivo Studies Assessment.
Elsayed SI; Girgis GNS; El-Dahan MS
Int J Nanomedicine; 2023; 18():721-742. PubMed ID: 36816332
[TBL] [Abstract][Full Text] [Related]
16. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
18. Calcium hydroxide-loaded PLGA biodegradable nanoparticles as an intracanal medicament.
Elmsmari F; González Sánchez JA; Duran-Sindreu F; Belkadi R; Espina M; García ML; Sánchez-López E
Int Endod J; 2021 Nov; 54(11):2086-2098. PubMed ID: 34355406
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
20. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]